Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women

Journal of Clinical Investigation

Volumn 107, Issue 3, 2001, Pages 287-294

  Patterson, Bruce K ^a   Behbahani, Homira ^b   Kabat, William J ^a   Sullivan, Yvonne ^c   O'Gorman, Maurice R G ^a   Landay, Alan ^c   Flener, Zareefa ^a   Khan, Nadia ^a   Yogev, Ram ^a   Andersson, Jan ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLACENTA; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0035132387     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11481     Document Type: Article

References (44)

1. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire
2. Elective Caesariansection versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial
3. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group protocol 185
4. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies
5. Epidemiology of pediatric human immunodeficiency virus infection in the United States
6. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission
7. TRAIL (Apo-2L) and TRAIL receptors in human placentae: Implications for immune privilege
8. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and conceptus
9. Inhibition of and selection against vertical HIV-1 transmission by the placenta
10. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp 120 epitopes correlates with the uninfected status of children born to seropositive mothers
11. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission
12. Anti-HIV effect of beta subunit of human chorionic gonadotropin (β-HCG) in vitro
13. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice
14. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease
15. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor
16. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
17. Repertoire of chemokine receptor expression in the female genital tract: Implications for human immunodeficiency virus transmission
18. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection
19. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
20. Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay
21. New soluble formazan assay for HIV- 1 cytopathic effects: Application to high flux screening of synthetic and natural products for AIDS-antimicrobial activity
22. Human immunodeficiency virus type 1 infection of human placenta: Potential route for fetal infection
23. Development of a human thymic organ culture model for the study of HIV pathogenesis
24. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract
25. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing anti-retroviral therapy
26. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes
27. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection
28. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription
29. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor
30. Signals through gp130 upregulate bcl-x gene expression via STATI-binding cis-element in cardiac myocytes
31. + T cells
32. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
33. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance
34. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones
35. Early spontaneous abortions and fetal thymic abnormalities in maternal-to-fetal HIV infection
36. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
37. Ciliary neurotropic factor, interleukin- 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
38. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL6β receptor components
39. Shc mediates IL-6 signaling by interacting with gp130 and JAK2 kinase
40. CD8+ Iymphocytes can control HIV infection in vitro by suppressing virus replication
41. Alloantigen-induced anti-HIV activity occurs prior to reverse transcription and can be generated by leukocytes from HIV-infected individuals
42. Alteration in bone marrow adherent layer growth factor expression: A novel mechanism of chronic myelogenous leukemia progression
43. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice
44. Production of human interleukin for DA cells (HILDA) by activated monocytes